Watch Ticker

CASI Pharmaceuticals, Inc. Ordinary Shares

Go to CASI Pharmaceuticals, Inc. Ordinary Shares Website

$1.61

-0.33 (-17.01%)

Live

Previous Close

$1.94

Day Range

$1.68 - $1.95

Previous Day Range

$1.86 - $2.15

Market Cap

$30.1 million USD

Day Vol.

475104

Previous Day Vol.

1.4 million

Currency

USD

Primary Exchange

Nasdaq

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is us...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

CASI Pharmaceuticals (CASI) gets a proposal letter from its chairman for acquiring its business operations in China. Its shares rise on the news.

Related tickers: CGEN, CASI, ANVS, ALXO.

Read Full Article

Benzinga Insights - HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of CASI Pharmaceuticals (NASDAQ:CASI) and raise its price target from $10.00 to $12.00. Shares of CASI Pharmaceuticals are trading up 1.33% over the last 24 hours, at $4.56 per share. A move to $12.00 would account for a 163.16% increase from the current share price. About CASI Pharmaceuticals CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. ...Full story available on Benzinga.com

Related tickers: CASI.

Read Full Article

Trending Tickers

Please sign in to view